GlassScriptPhysician profile
Midhat Syed
NPI 1437631512
$3,090.83
in general payments reported to CMS, 2019-2025
26 companies · $546 in 2025
The $546 reported for 2025 was more than what 81% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $310 · 2022: $478 · 2023: $1,075 · 2024: $682 · 2025: $546.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,302.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $706.73 | 2021-2025 | Collagenase Santyl, Grafix Pl, Renasys Touch |
| Tactile Systems Technology INC | $289.98 | 2021-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Abbvie INC. | $288.52 | 2021-2024 | |
| Solventum Corporation | $273.31 | 2024-2025 | Activ.A.C., Snap, 3m Cavilon |
| Kerecis Limited | $267.22 | 2021-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Surgiclose |
| Urgo Medical North America, LLC | $220.95 | 2023-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgoclean Ag, Urgok2 |
| Organogenesis INC. | $179.50 | 2022-2024 | Affinity, Puraply |
| Paratek Pharmaceuticals, INC. | $105.87 | 2023-2025 | Nuzyra |
| Convatec INC. | $92.50 | 2021-2023 | |
| Reprise Biomedical, INC. | $86.51 | 2023 | Miro3d, Miro3d Fibers, Miroflex |
| Boston Scientific Corporation | $76.23 | 2022-2025 | Varithena Administration Pack |
| Next Science LLC | $73.79 | 2022-2024 | Blastx, Xperience, Surgx |
| Aroa Biosurgery Incorporated | $50.66 | 2023 | |
| Mimedx Group, INC. | $49.40 | 2024-2025 | |
| Kci USA, INC. | $48.16 | 2022-2023 | Activ.A.C., V.A.C. Dermatac, 3m Cavilon |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $42.81 | 2025 | Tcc-Ez |
| Silk Road Medical, INC. | $41.57 | 2022 | |
| Reddress USA, INC. | $36.23 | 2025 | Actigraft |
| Teleflex LLC | $33.33 | 2022 | |
| Hydrofera LLC | $28.79 | 2023 | Hydrofera Blue |
| Hartmann USA, INC. | $20.83 | 2022 | |
| Lifenet Health | $20.80 | 2025 | Theragenesis Wound Matrix |
| Molnlycke Health Care US, LLC | $18.91 | 2025 | Exufiber, Mepilex, Mextra Superabsorbant |
| Ethicon US, LLC | $14.69 | 2022 | |
| Angiodynamics, INC. | $12.83 | 2022 | |
| Cashflow Solutions, LLC | $10.71 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Midhat Syed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.